PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26069510-10 2013 Direct covalent coupling of antibodies to nanoparticles using glutaraldehyde as a cross-linker is an appropriate method to achieve cell type-specific drug carrier systems based on PLGA-PEG nanoparticles and the anti-EGFR-decorated PLGA-PEG nanoparticles have potentials to be applied for targeted chemotherapy against EGFR positive cancers. Glutaral 62-76 epidermal growth factor receptor Homo sapiens 216-220 26069510-10 2013 Direct covalent coupling of antibodies to nanoparticles using glutaraldehyde as a cross-linker is an appropriate method to achieve cell type-specific drug carrier systems based on PLGA-PEG nanoparticles and the anti-EGFR-decorated PLGA-PEG nanoparticles have potentials to be applied for targeted chemotherapy against EGFR positive cancers. Glutaral 62-76 epidermal growth factor receptor Homo sapiens 318-322 21485840-2 2011 It was observed that direct covalent coupling of antibodies to glutaraldehyde activated nanoparticles is an appropriate method to achieve cell-type specific drug carrier systems based on polymeric nanoparticles that have potential to be applied for targeted chemotherapy in EGFR positive cancer. Glutaral 63-77 epidermal growth factor receptor Homo sapiens 274-278 9335547-3 1997 Dimerization of EGF receptor was monitored by immunoblotting the protein after it had been cross-linked with glutaraldehyde. Glutaral 109-123 epidermal growth factor receptor Homo sapiens 16-28 1316148-1 1992 Dimerization of epidermal growth factor receptor dissolved in a solution of nonionic detergent was followed with a resolution of 1 min by quantitative cross-linking with glutaraldehyde. Glutaral 170-184 epidermal growth factor receptor Homo sapiens 16-48